149 related articles for article (PubMed ID: 32375846)
1. Nomograms to predict 2-year overall survival and advanced schistosomiasis-specific survival after discharge: a competing risk analysis.
Li G; Lian L; Huang S; Miao J; Cao H; Zuo C; Liu X; Zhu Z
J Transl Med; 2020 May; 18(1):187. PubMed ID: 32375846
[TBL] [Abstract][Full Text] [Related]
2. Derivation and external validation of a model to predict 2-year mortality risk of patients with advanced schistosomiasis after discharge.
Li G; Huang S; Lian L; Song X; Sun W; Miao J; Li B; Yuan Y; Wu S; Liu X; Zhu Z
EBioMedicine; 2019 Sep; 47():309-318. PubMed ID: 31451437
[TBL] [Abstract][Full Text] [Related]
3. Nomograms and risk classification systems predicting overall and cancer-specific survival in primary malignant cardiac tumor.
Guan T; Li Y; Qiu Z; Zhang Y; Lin W; Lai Y; Wang K; Shen Y; Du L; Liu C
J Card Surg; 2019 Dec; 34(12):1540-1549. PubMed ID: 31794125
[TBL] [Abstract][Full Text] [Related]
4. Nomogram to Predict Cancer-Specific Survival in Patients with Pancreatic Acinar Cell Carcinoma: A Competing Risk Analysis.
He C; Zhang Y; Cai Z; Duan F; Lin X; Li S
J Cancer; 2018; 9(22):4117-4127. PubMed ID: 30519311
[No Abstract] [Full Text] [Related]
5. Competing risk analyses of overall survival and cancer-specific survival in patients with combined hepatocellular cholangiocarcinoma after surgery.
He C; Zhang Y; Cai Z; Lin X
BMC Cancer; 2019 Feb; 19(1):178. PubMed ID: 30813928
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of prognostic nomogram for germ cell testicular cancer patients.
Mao W; Wu J; Kong Q; Li J; Xu B; Chen M
Aging (Albany NY); 2020 Nov; 12(21):22095-22111. PubMed ID: 33136554
[TBL] [Abstract][Full Text] [Related]
7. Nomogram to Predict Cause-Specific Mortality in Patients With Surgically Resected Stage I Non-Small-Cell Lung Cancer: A Competing Risk Analysis.
Zhou H; Zhang Y; Qiu Z; Chen G; Hong S; Chen X; Zhang Z; Huang Y; Zhang L
Clin Lung Cancer; 2018 Mar; 19(2):e195-e203. PubMed ID: 29153966
[TBL] [Abstract][Full Text] [Related]
8. Melanoma-specific mortality and competing mortality in patients with non-metastatic malignant melanoma: a population-based analysis.
Shen W; Sakamoto N; Yang L
BMC Cancer; 2016 Jul; 16():413. PubMed ID: 27389173
[TBL] [Abstract][Full Text] [Related]
9. Can a Nomogram Help to Predict the Overall and Cancer-specific Survival of Patients With Chondrosarcoma?
Song K; Shi X; Wang H; Zou F; Lu F; Ma X; Xia X; Jiang J
Clin Orthop Relat Res; 2018 May; 476(5):987-996. PubMed ID: 29470233
[TBL] [Abstract][Full Text] [Related]
10. Identifying the Prognosis Factors and Predicting the Survival Probability in Patients with Non-Metastatic Chondrosarcoma from the SEER Database.
Huang R; Sun Z; Zheng H; Yan P; Hu P; Yin H; Zhang J; Meng T; Huang Z
Orthop Surg; 2019 Oct; 11(5):801-810. PubMed ID: 31663279
[TBL] [Abstract][Full Text] [Related]
11. Nomogram to predict cause-specific mortality of patients with rectal adenocarcinoma undergoing surgery: a competing risk analysis.
Zhang X; Xu F; Bin Y; Liu T; Li Z; Guo D; Li Y; Huang Q; Lyu J; He S
BMC Gastroenterol; 2022 Feb; 22(1):57. PubMed ID: 35144545
[TBL] [Abstract][Full Text] [Related]
12. Nomogram-Predicted Survival of Breast Cancer Brain Metastasis: a SEER-Based Population Study.
Xiong Y; Cao H; Zhang Y; Pan Z; Dong S; Wang G; Wang F; Li X
World Neurosurg; 2019 Aug; 128():e823-e834. PubMed ID: 31096027
[TBL] [Abstract][Full Text] [Related]
13. Model to Predict Cause-Specific Mortality in Patients with Head and Neck Adenoid Cystic Carcinoma: A Competing Risk Analysis.
Shen W; Sakamoto N; Yang L
Ann Surg Oncol; 2017 Aug; 24(8):2129-2136. PubMed ID: 28424937
[TBL] [Abstract][Full Text] [Related]
14. Prognostic nomograms and Aggtrmmns scoring system for predicting overall survival and cancer-specific survival of patients with kidney cancer.
Zhou Y; Zhang R; Ding Y; Wang Z; Yang C; Tao S; Liang C
Cancer Med; 2020 Apr; 9(8):2710-2722. PubMed ID: 32087609
[TBL] [Abstract][Full Text] [Related]
15. Model to predict cause-specific mortality in patients with olfactory neuroblastoma: a competing risk analysis.
Liu L; Zhong Q; Zhao T; Chen D; Xu Y; Li G
Radiat Oncol; 2021 Jun; 16(1):103. PubMed ID: 34112184
[TBL] [Abstract][Full Text] [Related]
16. Establishment and validation of prognostic nomograms to predict overall survival and cancer-specific survival for patients with osteosarcoma.
Yang QK; Lai QY; Wang Y; Wang Y; Yao ZX; Zhang XJ
Neoplasma; 2021 Mar; 68(2):434-446. PubMed ID: 33118831
[TBL] [Abstract][Full Text] [Related]
17. Nomograms for Estimating Cause-Specific Death Rates of Patients With Inflammatory Breast Cancer: A Competing-Risks Analysis.
Xu F; Yang J; Han D; Huang Q; Li C; Zheng S; Wang H; Lyu J
Technol Cancer Res Treat; 2021; 20():15330338211016371. PubMed ID: 34013802
[TBL] [Abstract][Full Text] [Related]
18. The role of surgery for atypical bronchopulmonary carcinoid tumor: Development and validation of a model based on Surveillance, Epidemiology, and End Results (SEER) database.
Chen X; Pang Z; Wang Y; Bie F; Zeng Y; Wang G; Du J
Lung Cancer; 2020 Jan; 139():94-102. PubMed ID: 31759223
[TBL] [Abstract][Full Text] [Related]
19. Nomograms that predict the survival of patients with adenocarcinoma in villous adenoma of the colorectum: a SEER-based study.
Tang CT; Zeng L; Yang J; Zeng C; Chen Y
BMC Cancer; 2020 Jun; 20(1):608. PubMed ID: 32600342
[TBL] [Abstract][Full Text] [Related]
20. Development and Validation of Nomograms Predicting Overall and Cancer-Specific Survival of Spinal Chondrosarcoma Patients.
Song K; Song J; Shi X; Wang H; Ma X; Xia X; Liang X; Lin K; Jiang J
Spine (Phila Pa 1976); 2018 Nov; 43(21):E1281-E1289. PubMed ID: 29664813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
